Welcome to our dedicated page for GENWORTH FINANCIAL SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENWORTH FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENWORTH FINANCIAL's regulatory disclosures and financial reporting.
Genworth Financial Inc. reports that Donald Smith & Co., Inc. and affiliated DSCO Value Fund, L.P. beneficially own 25,486,303 shares of Common Stock, representing 6.58% of the class as of 03/31/2026. The filing lists sole voting power 24,743,136 and sole dispositive power 25,249,506.
The filing states Donald Smith & Co., Inc. acts as investment adviser and that ultimate power to direct receipt of dividends and sale proceeds rests with its institutional clients; no single client owns more than 5% of the class, per the schedule.
Genworth Financial reported Q1 2026 total revenues of $1.78 billion, roughly flat versus $1.79 billion a year earlier. Income from continuing operations was $80 million, down from $90 million, with net income available to common stockholders of $47 million versus $54 million.
Basic and diluted EPS were $0.12, compared with $0.13. Operating cash flow improved to $91 million from $34 million. Total investments were $58.5 billion, and total assets were $86.8 billion with equity of $9.84 billion as of March 31, 2026.
Under a $350 million share repurchase program, the company bought 7.7 million shares in Q1 2026 for $67 million at an average price of $8.61, and a further 2.2 million shares in April at $8.53, leaving about $175 million authorized as of April 30, 2026.
Genworth Financial reported first quarter 2026 net income of $47M, or $0.12 per diluted share, on total revenues of $1.78B. The company’s new primary performance measure, adjusted operating income excluding Closed Block, was $109M, or $0.28 per diluted share.
The Enact mortgage insurance segment generated adjusted operating income of $140M, with primary new insurance written of $12.8B and a loss ratio of 15%. Enact’s PMIERs sufficiency ratio was 162%, or $1.9B above requirements, and it increased its quarterly dividend to $0.24 per share.
The Closed Block long-term care and life businesses posted an adjusted operating loss of $32M, including a $36M pre-tax actual-versus-expected loss and GLIC consolidated RBC ratio of 289%. Holding-company cash and liquid assets were $166M, and Genworth repurchased $66M of shares in the quarter, bringing total buybacks since program inception to $856M.
Genworth Financial Inc filed a Form 13F reporting its institutional holdings as of the report period. The filing lists 2 information-table entries with a reported aggregate value of $427,736,917. The form is signed by Darren W. Woodell, Vice President and Controller, on 04-30-2026.
Genworth Financial Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 20,832,785 shares of common stock, representing 5.4% of the class. The filing states Vanguard entities and affiliated divisions exercise dispositive power over these shares and that holdings include securities held for Vanguard funds and managed accounts.
Genworth Financial Inc reports that Vanguard Portfolio Management beneficially owned 23,628,893 shares of common stock, representing 6.13% of the class as of 03/31/2026. The filing states Vanguard has sole power to dispose over 23,628,893 shares and sole voting power for 215,269 shares. The filing notes ownership includes securities held by Vanguard funds and certain affiliates over which Vanguard Portfolio Management or its affiliates exercise dispositive or voting power.
Genworth Financial Inc ownership filing reports that The Vanguard Group beneficially owns 0 shares of Common Stock, representing 0% of the class. The filing states Vanguard completed an internal realignment on January 12, 2026 and certain subsidiaries now report separately in reliance on SEC Release No. 34-39538.
The statement explains those subsidiaries pursue the same investment strategies and that Vanguard no longer is deemed to beneficially own securities held by those entities.
Genworth Financial, Inc. shareholder Scott Klarquist submitted an open letter and four shareholder proposals seeking (1) a special committee to consider strategic alternatives for Genworth's stake in Enact Holdings, (2) proxy access, (3) enhanced CEO succession planning disclosure and (4) an in-person annual meeting option.
Klarquist cites an Enact stake of 115,223,783 shares as of December 31, 2025 and notes a cited enterprise value comparison of $3.7 billion versus Enact market value just over $4.6 billion, arguing this gap implies a per-share arithmetic value near $10.46 versus Genworth's recent stock price around $8.16.
Genworth Financial is soliciting proxies for its 2026 Annual Meeting to be held virtually on May 20, 2026 and asks stockholders to vote on election of ten directors, advisory approval of executive compensation, a new Associate Stock Purchase Plan, and ratification of KPMG as auditor.
The letter highlights 2025 progress: $245 million of share repurchases at an average price of $7.99, a new $350 million repurchase authorization, $558 million of adjusted operating income at Enact, Genworth's Enact-related book value of $4.4 billion at year-end 2025, and receipt of $407 million of Enact capital returns. The company emphasizes CareScout growth, the acquisition of Seniorly, a pilot to enhance long-term care claims experience, and creation of a permanent Technology Committee.